Skip to content
Covid-19: the hospital situation is “serious”, alert Gabriel Attal – Coronavirus

Gabriel Attal: “The hospital situation is serious and requires us to continue our collective mobilization”

The “hospital situation is serious”, which justifies that nearly 8,000 beds are now armed in intensive care, said Thursday Government spokesman Gabriel Attal. One of the government’s priorities, “is to anticipate the arrival of the peak in intensive care, by continuing to arm more intensive care beds,” said the Secretary of State at the exit of the Council of Ministers, recalling that near 31,000 French people are hospitalized, including 5,746 in intensive care.

“We have already gone to nearly 8,000 armed beds in intensive care and we will continue to gradually rise to above 10,000 each time that is necessary,” he said. The health situation is “extremely worrying” in “certain regions” such as Auvergne-Rhône-Alpes, where the number of patients admitted to critical care has increased by 25% in one week.

“The incidence rate in our country remains very high” with “more than 400 cases per 100,000 inhabitants”. So “this is not the time to let go,” he said.

The milestone of 10 million first injections

In addition, France is preparing Thursday to exceed the 10 million first injections of vaccines against Covid-19, a symbolic bar but still very far from total protection in the face of the epidemic, which increasingly fills the services of intensive care. With 9,797,957 first injections on Wednesday, and at a daily rate of 200,000 to 300,000, the 10 million promised for mid-April by the government will be reached a few days in advance. Next caps: 20 million first doses in mid-May, then 30 million in mid-June.

Covid-19: the latest news live

Since the very first injection in the shoulder of Mauricette, a resident of Ehpad, on December 27, the vaccination campaign in France has rarely looked like a long quiet river: marked at first by a delay in ignition, it was then shaken, like other European countries, by the disappointments of AstraZeneca, between drops in deliveries and questions about side effects, more relevant than ever.

Support a professional editorial staff at the service of Brittany and the Bretons: subscribe from € 1 per month.

I subscribe

Source link